Biopharm Business - BioPharm International

ADVERTISEMENT

Biopharm Business
Insight and analysis to business aspects of biopharmaceutical development. Mergers, acquisitions, legal activities.

A Look at INTERPHEX 2012

April 1, 2012

Collaboration can begin with a conversation.

Manufacturers Wrestle with Drug Abuse and Critical Shortages

April 1, 2012

Soaring opioid use creates challenges for new drug development and supply-chain control.

PDA Tackles Changing Industry Times

April 1, 2012

The confluence of science, technology, and regulation will provide our industry with the guidance to move forward.

Growing Your Biopharmaceutical Product Pipeline

April 1, 2012

BioPharm talks with Tarja Mottram, CEO of Action for Results, about key business considerations when starting out.

Ways to Recover Lost Margins

April 1, 2012

Recovery audits and other best practices in procurement can improve the bottom line.

Small Changes, System-Wide Impact

April 1, 2012

A closer look at elastomer changeout times provides one example of using industry knowledge to improve operations and cost.

A Strong Start to 2012

April 1, 2012

Better news about the global economy buoys life-sciences funding.

Knowledge Management Implementation

April 1, 2012

The authors discuss the technology and guidance required to achieve good KM in a biopharmaceutical company.

The Growing Orphan-Drug Paradigm

April 1, 2012

Rather than seeking a single indication for one large group, the orphan-drug approach segments the market for a drug more minutely.

ADVERTISEMENT

ADVERTISEMENT

Click here